Russell W. Olson
Keine laufenden Positionen mehr
Profil
Russell W.
Olson has served as our Vice President, Regulatory, Quality and Clinical Affairs since February 2005.
From September 2000 to February 2005, he served as our Vice President, Regulatory and Quality.
From March 2000 to September 2000, Mr. Olson served as a Principal for the Regulatory and Clinical Research Institute, Inc., a consulting company, where he advised medical device companies on projects related to regulatory affairs, quality assurance and FDA matters.
From March 1998 to March 2000, Mr. Olson served as Director of Regulatory Affairs for Acorn Cardiovascular, Inc., a medical device company, where he was responsible for all regulatory aspects of a Class III passive implantable cardiac support device.
Prior to that, Mr. Olson was Director of Regulatory Affairs for InControl, Inc. He received a B.S.
in Microbiology and Public Health from the University of Wisconsin
Ehemalige bekannte Positionen von Russell W. Olson
Unternehmen | Position | Ende |
---|---|---|
CryoCor, Inc.
CryoCor, Inc. Medical SpecialtiesHealth Technology CryoCor, Inc. provided medical technology services. It developed and manufactured a disposable catheter system based on its proprietary cryoablation technology for the minimally invasive treatment of cardiac arrhythmias. The firm's product the CryoCor Cardiac Cryoablation System, was designed to treat cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The company was founded in 2000 and was headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
CryoCor, Inc.
CryoCor, Inc. Medical SpecialtiesHealth Technology CryoCor, Inc. provided medical technology services. It developed and manufactured a disposable catheter system based on its proprietary cryoablation technology for the minimally invasive treatment of cardiac arrhythmias. The firm's product the CryoCor Cardiac Cryoablation System, was designed to treat cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The company was founded in 2000 and was headquartered in San Diego, CA. | Health Technology |